Prediction of proximal advanced neoplasia: A comparison of four existing sigmoidoscopy-based strategies in a Chinese population

Gut

Volumn 64, Issue 5, 2015, Pages 776-783

  Wong, Martin C S ^a,b   Ching, Jessica Y L ^a   Ng, Siew C ^a,b   Wong, Sunny ^a,b   Chan, Victor C W ^a   Shum, Jeffrey P ^a   Lam, Thomas Y T ^a   Luk, Arthur K C ^a   Sung, Joseph J Y ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; AGE DISTRIBUTION; AGED; ARTICLE; ASYMPTOMATIC DISEASE; CANCER CLASSIFICATION; CANCER SCREENING; CHINESE; COHORT ANALYSIS; COLORECTAL CANCER; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HIGH RISK POPULATION; HONG KONG; HUMAN; INTERMEDIATE RISK POPULATION; INTERMETHOD COMPARISON; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; NORWEGIAN COLORECTAL CANCER PREENTION SCORE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; SCREENING FOR COLON RECTUM SCORE; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SIGMOIDOSCOPY; UNITED KINGDOM; UNITED KINGDOM FLEXIBLE SIGMOIDOSCOPY SCORE; UNITED STATES; UNITED STATES CLINICAL INDEX SCORE; COLONOSCOPY; COLORECTAL NEOPLASMS; COMPARATIVE STUDY; EARLY DIAGNOSIS; EVALUATION STUDY; MIDDLE AGED; PATHOLOGY; PATIENT REFERRAL; PREDICTIVE VALUE; PROCEDURES; RISK FACTOR; SEX RATIO; STATISTICS AND NUMERICAL DATA;

AGE DISTRIBUTION; AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HONG KONG; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REFERRAL AND CONSULTATION; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEX DISTRIBUTION; SIGMOIDOSCOPY;

EID: 84929454971     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2014-308002     Document Type: Article

References (46)

1. GLOBOCAN 2012. Cancer Fact Sheet. Colorectal Cancer Incidence, Mortality and Prevalence Worldwide in 2012. http://globocan.iarc.fr/Pages/fact-sheets-cancer.aspx (accessed 10 Jun 2014).
2. Sung JJY, Lau JYW, Goh KL, et al.; for the on Asia Pacific Working Group on Colorectal Cancer. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol 2005;6:871-6.
3. Nishihara R, Wu K, Lochhead P, et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med 2013;369:1095-105.
4. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008;58:130-60.
5. Yeoh KG, Ho KY, Chiu HM, et al.; for the Asia Pacific Working Group on Colorectal Cancer. The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects. Gut 2011;60:1236-41.
6. Sung JJ, Chan FK, Chiu HM; the Asia Pacific Working Group on Colorectal Cancer Screening. An updated Asia Pacific consensus recommendations on colorectal cancer screening. Gut 2008;57:1166-76.
7. Hoff G, Grotmol T, Skovlund E, et al. Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomized controlled trial. BMJ 2009;338: b1846.
8. Atkin WS, Edwards R, Kralj-Hans I, et al.; UK Flexible Sigmoidoscopy Trial Investigators. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010;375:1624-33.
9. Segnan N, Senore C, Andreoni B, et al.; SCORE Working Group-Italy. Baseline findings of the Italian multicentre randomised controlled trial of "once-only sigmoidoscopy"-SCORE. J Natl Cancer Inst 2002;94:1763-72.
10. Weissfeld JL, Schoen RE, Pinsky PF, et al.;. Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial. J Natl Cancer Inst 2005;97:989-97.
11. Segnan N, Patnick J, von Karsa L, eds. European guidelines for quality assurance in colorectal cancer screening and diagnosis. Luxembourg: Publications Office of the European Union, 2010.
12. Salkeld GP, Young JM, Solomon MJ. Consumer choice and the National Bowel Cancer Screening Program. Med J Aust 2006;184:541-2.
13. Imperiale TF, Wagner DR, Lin CY, et al. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med 2000;343:169-74.
14. Read TE, Read JD, Butterly LF. Importance of adenomas 5 mm or less in diameter that are detected by sigmoidoscopy. N Engl J Med 1997;336:8-12.
15. Levin TR, Palitz A, Grossman S, et al. Predicting advanced proximal colonic neoplasia with screening sigmoidoscopy. JAMA 1999;281:1611-17.
16. Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010;375:1624-33.
17. Segnan N, Armaroli P, Bonelli L. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian randomized controlled trial-SCORE. J Natl Cancer Inst 2011;103:1310-22.
18. Bretthauer M, Gondal G, Larsen IK. Design, organization and management of a controlled population screening study for detection of colorectal neoplasia attendance rates in the NORCCAP study (Norwegian Colorectal Cancer Prevention). Scand J Gastroenterol 2002;37:568-73.
19. Imperiale TF, Wagner DR, Lin CY, et al. Using risk for advanced proximal colonic neoplasia to tailor endoscopic screening for colorectal cancer. Ann Intern Med 2003;139:959-65.
20. Castells A, Bessa X, Quintero E, et al. Risk of advanced proximal neoplasms according to distal colorectal findings: comparison of sigmoidoscopy-based strategies. J Natl Cancer Inst 2013;105:878-86.
21. Quintero E, Castells A, Bujanda L, et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med 2012;366:697-706.
22. Soon MS, Kozarek RA, Ayub K, et al. Screening colonoscopy in Chinese and Western patients: a comparative study. Am J Gastroenterol 2005;100:2749-55.
23. Byeon JS, Yang SK, Kim TII, et al. Colorectal neoplasm in asymptomatic Asians: a prospective multinational multicenter colonoscopy survey. Gastrointest Endosc 2007;65:1015-22.
24. Shavers VL. Racial/ethnic variation in the anatomic subsite location of in situ and invasive cancers of the colon. J Natl Med Assoc 2007;99:733-48.
25. Lieberman DA, Holub JL, Moravec MD, et al. Prevalence of colon polyps detected by colonoscopy screening in asymptomatic black and white patients. JAMA 2008;300:1417-22.
26. Wong MCS, Lam TYT, Tsoi KKF, et al. A validated tool to predict colorectal neoplasia and inform screening choice for asymptomatic subjects. Gut 2014;63:1130-6.
27. Wong MCS, Lam TYT, Tsoi KKF, et al. Predictors of colorectal advanced neoplasia for colorectal cancer screening. Am J Prev Med 2014;46:433-9.
28. Wong MC, Hirai HW, Luk AK, et al. The knowledge of colorectal cancer symptoms and risk factors among 10,078 screening participants: are high risk individuals more knowledgeable? PLoS ONE 2013;8:e60366.
29. Wong MC, Ching JY, Hirai HH, et al. Perceived obstacles of colorectal cancer screening and their associated factors among 10,078 Chinese participants. PLoS ONE 2013;8:e70209.
30. Wong MCS, John GK, Hirai HW, et al. Changes in the choice of colorectal cancer screening tests in primary care settings from 7,845 prospectively collected surveys. Cancer Causes Control 2012;23:1541-8.
31. Ng SC, Ching JYL, Chan VCW, et al. Diagnostic accuracy of fecal immunochemical test for screening individuals with a family history of colorectal cancer. Aliment Pharmacol Ther 2013;38:835-41.
32. Wong MCS, Ching JY, Lam TY, et al. Prospective cohort study of compliance with faecal immunochemical tests for colorectal cancer screening in Hong Kong. Prev Med 2013;57:227-31.
33. Wong MCS, Tsoi KKF, Ng SSM, et al. A Comparison of the acceptance of Immunochemical faecal occult blood test and colonoscopy in colorectal cancer screening: a prospective study among Chinese. Aliment Pharmacol Ther 2010;32:74-82.
34. Wong MCS, Ching JY, Chan VC, et al. Informed choice vs. no choice in colorectal cancer screening tests: a prospective cohort study in real-life screening practice. Am J Gastroenterol 2014;109:1072-9.
35. Imperiale TF, Wagner DR, Lin CY, et al. Results of screening colonoscopy among persons 40 to 49 years of age. N Engl J Med 2002;346:1781-5.
36. Hanley JA, McNeil BJ. The meaning and the use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.
37. Brenner H, Stock C, Hoffmeister M. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ 2014;348:g2467.
38. Schoenfeld P, Cash B, Flood A, et al. Colonoscopic screening of average risk women for colorectal neoplasia. N Engl J Med 2005;352:2061-8.
39. Lieberman DA, Weiss DG, Bond JH, et al. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. N Engl J Med 2000;343:207-8.
40. Levin B, Lieberman DA, McFarland B, et al.; American Cancer Society Colorectal Cancer Advisory Group. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008;134:1570-95.
41. Bensen S, Mott LA, Dain B, et al. The colonoscopic miss rate and true one-year recurrence rate of colorectal neoplastic polyps. Polyp Prevention Study Group. Am J Gastroenterol 1999;94:194-9.
42. Rex DK, Cutler CS, Lemmei GT, et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 1997;112:24-8.
43. Sung JJ, Lau JY, Young GP, Asia Pacific Working Group on Colorectal Cancer, et al. Asia Pacific consensus recommendations for colorectal cancer screening. Gut 2008;57:1166-76.
44. Levitzky BE, Brown CC, Heeren TC, et al. Performance of a risk index for advanced proximal colorectal neoplasia among a racially/ethnically diverse patient population (risk index for advanced proximal neoplasia). Am J Gastroenterol 2011;106:1099-106.
45. Castells A, Quintero E, Alvarez C, et al. Rate of detection of advanced neoplasms in proximal colon by simulated sigmoidoscopy vs fecal immunochemical tests. Clin Gastroenterol Hepatol Published Online First: 27 Mar 2014.
46. Wong MC, Ching JY, Chan VC, et al. Factors associated with false-positive and false-negative fecal immunochemical test results for colorectal cancer screening. Gastrointest Endosc 2014. In press.